Article Information
vol. 5 no. 44
- Received August 29, 2019
- Revision received November 11, 2019
- Accepted January 30, 2020
- .
Author Information
- Tianshi Lu1,
- Shidan Wang1,
- Lin Xu1,2,
- Qinbo Zhou1,
- Nirmish Singla3,4,
- Jianjun Gao5,
- Subrata Manna6,
- Laurentiu Pop6,
- Zhiqun Xie1,
- Mingyi Chen7,
- Jason J. Luke8,
- James Brugarolas4,9,
- Raquibul Hannan4,6 and
- Tao Wang1,4,*
- 1Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 2Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 3Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 4Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 5Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- 6Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 7Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- 8University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
- 9Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
- ↵*Corresponding author. Email: tao.wang{at}utsouthwestern.edu